Published in J Clin Microbiol on April 01, 1993
Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol (2015) 0.99
Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine. Int J Med Sci (2011) 0.83
Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus Vaccine. Int J Biomed Sci (2009) 0.81
Cellular and humoral immunity of virus-induced asthma. Front Microbiol (2013) 0.81
Undetectable IgE responses after respiratory syncytial virus infection. Arch Dis Child (1996) 0.77
Role of viruses in the development of atopic disease in pediatric patients. Curr Allergy Asthma Rep (2012) 0.76
The Human Immune Response to Respiratory Syncytial Virus Infection. Clin Microbiol Rev (2017) 0.75
Need for a safe vaccine against respiratory syncytial virus infection. Korean J Pediatr (2012) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol (1969) 10.85
An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol (1969) 6.85
Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol (1973) 3.77
Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr (1976) 2.45
Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol (1989) 2.17
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol (1986) 1.79
Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol (1980) 1.51
Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus. J Pediatr (1987) 1.02
Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection. J Clin Microbiol (1989) 0.95
Microbial agents associated with pneumonia in children from Uruguay. Rev Infect Dis (1991) 0.91
Identification of viruses in a study of acute respiratory tract infection in children from Uruguay. Rev Infect Dis (1991) 0.82
[Acute intrathoracic respiratory infections in hospitalized children. Uruguay 1984-1986]. Bol Med Hosp Infant Mex (1990) 0.81
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol (1994) 2.29
Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol (1997) 2.13
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A (2001) 2.04
Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J Clin Microbiol (2001) 1.88
Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology (2000) 1.87
Monoclonal antibodies specific for African swine fever virus proteins. J Virol (1985) 1.73
Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology (1994) 1.69
Molecular epidemiology of adenovirus acute lower respiratory infections of children in the south cone of South America (1991-1994). J Med Virol (1996) 1.60
Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies. J Virol (1991) 1.50
Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol (1998) 1.50
Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity. Virology (1990) 1.33
Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology (1997) 1.31
Evolution of the capsular gene locus of Streptococcus pneumoniae serogroup 6. Microbiology (2010) 1.31
Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics (1999) 1.31
Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus. J Virol (1990) 1.26
Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. PAHO Sireva-Vigía Study Group. Pan American Health Organization. Pediatr Infect Dis J (2001) 1.18
Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study. Clin Infect Dis (1998) 1.17
Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: the use of alternative termination codons and lineage diversification. J Gen Virol (1999) 1.13
The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity. J Gen Virol (1991) 1.12
Serological evidence of human Hantavirus infection in Argentina, Bolivia and Uruguay. Medicina (B Aires) (1996) 1.10
Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein. Virology (1996) 1.06
The apparent importation of penicillin-resistant capsular type 14 Spanish/French clone of Streptococcus pneumoniae into Uruguay in the early 1990s. Microb Drug Resist (1998) 1.04
Monoclonal antibodies of African swine fever virus: antigenic differences among field virus isolates and viruses passaged in cell culture. J Virol (1986) 1.00
The three C-terminal residues of human respiratory syncytial virus G glycoprotein (Long strain) are essential for integrity of multiple epitopes distinguishable by antiidiotypic antibodies. Viral Immunol (1995) 0.98
Colonizing and invasive strains of Streptococcus pneumoniae in Uruguayan children: type distribution and patterns of antibiotic resistance. Pediatr Infect Dis J (1992) 0.95
Genotypes of respiratory syncytial virus group B identified in Uruguay. Arch Virol (2004) 0.93
Antigenic characterization of respiratory syncytial virus associated with acute respiratory infections in Uruguayan children from 1985 to 1987. J Clin Microbiol (1989) 0.93
Evolution of the G and P genes of human respiratory syncytial virus (subgroup A) studied by the RNase A mismatch cleavage method. Virology (1991) 0.89
A point mutation in the F1 subunit of human respiratory syncytial virus fusion glycoprotein blocks its cell surface transport at an early stage of the exocytic pathway. J Gen Virol (1996) 0.85
Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies. J Virol (1990) 0.83
Respiratory syncytial virus subgroups and pneumonia in children. Lancet (1989) 0.83
Simple clinical signs for diagnosis of acute respiratory infections. Lancet (1989) 0.82
[Determination of bactericidal antibodies directed against vibrio cholerae in an adult population in Montevideo]. Rev Argent Microbiol (1996) 0.82
Recent measles viral activity in Uruguai: serological and genetic approaches. Acta Virol (2000) 0.81
Mapping of monoclonal antibody epitopes of the human respiratory syncytial virus p protein. Virology (1993) 0.79
Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations. Vaccine (2003) 0.79
[Antigenic variants of the respiratory syncytial virus in Argentina and Uruguay]. Rev Argent Microbiol (1989) 0.78
Genome type analysis of South American adenoviruses of subgenus C collected over a 7-year period. Arch Virol (1993) 0.77
[Comparison between immunofluorescence and immunoenzymatic assay for the rapid diagnosis of the respiratory syncytial virus in nasopharyngeal secretions]. Rev Argent Microbiol (1989) 0.75
Meningitis caused by Neisseria meningitidis C relatively resistant to penicillin and ampicillin. Pediatr Infect Dis J (1996) 0.75